MentalHealthDaily

Anti-CGRP Monoclonal Antibodies to Prevent Chronic Migraine (2023 Review)

Migraine, a primary headache disorder, significantly impacts the quality of life of millions worldwide. In recent years, the focus has shifted toward developing targeted therapies, particularly monoclonal antibodies (mAbs) against the calcitonin-gene-related peptide (CGRP), to prevent chronic migraine attacks. A relatively recent comprehensive network meta-analysis (NMA) evaluated the efficacy and safety of various anti-CGRP mAbs, …

Daith Piercings for Migraine: An Experimental Intervention

by GLOOM

A Daith piercing is a specific type of ear piercing in which the ear’s innermost cartilage fold (i.e. the crus of helix) is penetrated and pierced with a specialized curved needle. According to experts, for a piercing to qualify as a legitimate “Daith piercing” – it must be performed such that the bottom part of …

Zoloft (Sertraline) & Headaches: Does It Cause or Treat Headaches?

by GLOOM

Zoloft (Sertraline), is an SSRI (selective serotonin reuptake inhibitor) prescribed for the treatment of major depressive disorder, OCD (obsessive-compulsive disorder), panic disorder, and social anxiety disorder. It was approved by the FDA in 1991 and initially marketed by the pharmaceutical company Pfizer. In 2013, Zoloft became the single most popular antidepressant medication in the United …